Kevin P. Starr's most recent trade in Sage Therapeutics Inc was a trade of 10,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 15, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sage Therapeutics Inc | Kevin P. Starr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kevin P. Starr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 9,947 | 9,947 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kevin P. Starr | Director | Purchase of securities on an exchange or from another person at price $ 56.05 per share. | 16 Jun 2021 | 17,842 | 320,659 (0%) | 0% | 56.0 | 999,983 | Common Stock |
| Sage Therapeutics Inc | Kevin P. Starr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) |